ALK

Clinical trials for ALK explained in plain language.

Never miss a new study

Get alerted when new ALK trials appear

Sign up with your email to follow new studies for ALK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for lung cancer patients who've run out of options?

Disease control Recruiting now

This study is for people with a specific type of advanced lung cancer (ALK-positive) that has gotten worse during or after treatment with the drug lorlatinib. Researchers want to see if a different drug, iruplinalkib, can help control the cancer for a longer time. About 20 adults…

Matched conditions: ALK

Sponsor: Peking University Shenzhen Hospital • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

ALK

Get alerted when new ALK trials appear

New hope for lung cancer patients who've run out of options?